Magdalena Plebanski Selected Research

Epitopes

8/2021	Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy.
7/2020	Functional Recognition by CD8+ T Cells of Epitopes with Amino Acid Variations Outside Known MHC Anchor or T Cell Receptor Recognition Residues.
3/2017	Understanding CD8+ T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope.
1/2015	Montanide, Poly I:C and nanoparticle based vaccines promote differential suppressor and effector cell expansion: a study of induction of CD8 T cells to a minimal Plasmodium berghei epitope.
2/2014	Antibodies to a single, conserved epitope in Anopheles APN1 inhibit universal transmission of Plasmodium falciparum and Plasmodium vivax malaria.
9/2011	The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
5/2006	Dimorphic Plasmodium falciparum merozoite surface protein-1 epitopes turn off memory T cells and interfere with T cell priming.
4/2004	A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.
4/2003	Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection.
3/2002	Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Magdalena Plebanski Research Topics

Disease

39	Neoplasms (Cancer) 10/2023 - 05/2002
28	Malaria 11/2020 - 01/2002
22	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 06/2012
18	Infections 02/2024 - 04/2003
18	Inflammation (Inflammations) 10/2022 - 06/2010
6	Overweight 10/2022 - 11/2017
5	Diphtheria 01/2020 - 10/2004
5	Communicable Diseases (Infectious Diseases) 08/2009 - 10/2004
4	Human Influenza (Influenza) 10/2021 - 01/2013
4	Tetanus 01/2020 - 01/2015
4	Whooping Cough (Pertussis) 01/2020 - 01/2015
4	Asthma (Bronchial Asthma) 01/2013 - 01/2007
3	Ascites 01/2023 - 01/2017
3	Breast Neoplasms (Breast Cancer) 08/2022 - 01/2006
3	Ovarian Epithelial Carcinoma 06/2021 - 01/2017
3	Measles 01/2020 - 01/2015
3	Pneumonia (Pneumonitis) 11/2018 - 01/2017
3	Virus Diseases (Viral Diseases) 06/2010 - 04/2007
2	Insulin Resistance 10/2022 - 01/2019
2	Carcinogenesis 08/2022 - 01/2022
2	COVID-19 01/2022 - 01/2021
2	Autoimmune Diseases (Autoimmune Disease) 08/2021 - 01/2021
2	Cytomegalovirus Infections (Inclusion Disease) 07/2020 - 01/2020
2	Obesity 02/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 12/2019 - 01/2006
2	Necrosis 01/2019 - 11/2017
2	Wilms Tumor (Wilm's Tumor) 01/2018 - 03/2017
2	Hypersensitivity (Allergy) 01/2018 - 01/2017
2	Poliomyelitis (Polio) 03/2016 - 10/2004
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2014 - 02/2014
2	Vivax Malaria 02/2014 - 04/2011
2	Chronic Hepatitis C 12/2009 - 04/2007
1	Immune System Diseases (Immune Disorders) 10/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2023

Drug/Important Bio-Agent (IBA)

37	VaccinesIBA 02/2024 - 01/2002
24	AntigensIBA 02/2024 - 05/2002
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2003
17	CytokinesIBA 10/2022 - 02/2003
13	Peptides (Polypeptides)IBA 02/2024 - 05/2002
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2014
10	EpitopesIBA 08/2021 - 03/2002
9	Type II Tumor Necrosis Factor ReceptorsIBA 08/2022 - 10/2013
8	AntibodiesIBA 01/2022 - 02/2003
7	Polystyrenes (Polystyrene)IBA 07/2020 - 02/2012
6	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022 - 04/2009
6	AutoantibodiesIBA 01/2022 - 12/2013
6	LigandsIBA 06/2021 - 05/2006
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2017
5	Interferon-gamma (Interferon, gamma)IBA 11/2020 - 04/2003
4	Immunologic Factors (Immunomodulators)IBA 01/2023 - 04/2009
4	AdipokinesIBA 10/2022 - 09/2018
4	Interleukin-4 (Interleukin 4)IBA 11/2020 - 09/2004
4	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 07/2020 - 05/2006
4	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 05/2013
4	AllergensIBA 01/2018 - 02/2012
3	AdiponectinIBA 10/2022 - 09/2018
3	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 09/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2017
3	EnzymesIBA 06/2021 - 01/2018
3	Vitamin D FDA LinkGeneric 02/2020 - 11/2017
3	Cancer VaccinesIBA 01/2018 - 09/2008
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2017 - 09/2011
3	Merozoite Surface Protein 1 (MSA1)IBA 02/2010 - 03/2002
2	LipidsIBA 10/2022 - 01/2019
2	Hormones (Hormone)IBA 08/2022 - 01/2019
2	Immunoglobulin G (IgG)IBA 01/2022 - 09/2011
2	AutoantigensIBA 01/2022 - 08/2021
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 01/2021
2	CarnosineIBA 03/2021 - 09/2018
2	AntioxidantsIBA 01/2021 - 01/2020
2	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2021 - 11/2015
2	Vaccine AdjuvantsIBA 07/2020 - 01/2018
2	Tranexamic Acid (AMCA)FDA Link 12/2019 - 01/2019
2	Cholecalciferol (Vitamin D3)FDA Link 01/2019 - 11/2017
2	hydroxide ionIBA 01/2019 - 11/2017
2	NanovaccinesIBA 01/2018 - 09/2004
2	C-Reactive ProteinIBA 11/2017 - 06/2014
2	PolyethyleneimineIBA 02/2017 - 05/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2017 - 08/2009
2	Measles VaccineIBA 01/2017 - 11/2016
2	Monoclonal AntibodiesIBA 01/2017 - 02/2003
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2016 - 01/2016
2	PlatinumIBA 01/2016 - 01/2015
2	Azacitidine (5 Azacytidine)FDA Link 04/2015 - 02/2014
2	Lenalidomide (CC 5013)FDA Link 04/2015 - 08/2014
2	DNA VaccinesIBA 05/2013 - 03/2007
2	activin AIBA 01/2013 - 06/2010
2	Interleukin-13IBA 05/2011 - 06/2010
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2010 - 08/2009
2	Interleukin-2 (IL2)IBA 08/2009 - 02/2003
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 02/2024
1	CholesterolIBA 02/2024
1	LipopeptidesIBA 02/2024
1	Therapeutic UsesIBA 10/2023
1	Complement Factor D (Factor D)IBA 10/2022
1	Selective Estrogen Receptor Modulators (SERM)IBA 08/2022

Therapy/Procedure

20	Therapeutics 10/2023 - 02/2003
16	Immunotherapy 08/2022 - 02/2003
10	Drug Therapy (Chemotherapy) 09/2021 - 09/2008
1	Mediterranean Diet 10/2022